We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Bile Enables Norovirus to Grow in Laboratory Cell Cultures

By LabMedica International staff writers
Posted on 07 Sep 2016
Bile proved to be the key to the first successful growth of norovirus in laboratory cell cultures.

Noroviruses (NoVs) are a leading cause of gastroenteritis globally, yet the host factors required for NoV infection are poorly understood. More...
Human norovirus will not infect any of the species typically used in biomedical research, such as mice, rats, or rabbits nor will it grow in human cell cultures.

After the failure of many previous attempts to cultivate norovirus in cell cultures, investigators at Baylor College of Medicine (Houston, TX, USA) turned to a recently developed human intestinal epithelial cell culture system that included enterocytes. These novel, multi-cellular human cultures, called enteroids, were made from adult intestinal stem cells from patient tissues.

The investigators reported in the August 25, 2016, online edition of the journal Science that novel cell culture system not withstanding, the method was not impressively successful until they added bile, a critical factor of the intestinal milieu. With the addition of bile, the culture system recapitulated the human intestinal epithelium, permitting human host-pathogen studies of previously non-cultivatable pathogens, and allowed the assessment of methods to prevent and treat human NoV infections.

"When we added bile to the cultures, norovirus strains that did not grow before now grew in large numbers," said senior author Dr. Mary Estes, professor of human and molecular virology and microbiology at Baylor College of Medicine. "People have been trying to grow norovirus in the lab for a very long time. We tried for the last 20 years. Despite all the attempts and the success of growing other viruses, it remained a mystery why noroviruses were so hard to work with. We were able to grow norovirus in cultures that mimic the intestinal environment, where the virus naturally grows, by adding bile to the cultures. Bile is critical for several important bacterial pathogens, but this is the first time it has been shown that bile is important for the replication of human intestinal viruses."

Related Links:
Baylor College of Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Thyroid Test
Anti-Thyroid EIA Test
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.